Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a …

Biotechnology

US, San Diego [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Heron Therapeutics, Inc.

Heron Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

152,095,000

Volume

415,790

Volume on Avg.

3,203,918

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $1.51 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Kaseta Michael Internal : Director	0	$0	11/05/24	0 x $0 = $0
Duarte Ira Internal : EVP, Chief Financial Officer	100,252	$151,380.52	06/17/24	M 12,500 x $0 = $0
Forbes William P Internal : EVP, Chief Development Officer	95,374	$144,014.74	06/07/24	M 12,500 x $0 = $0
Collard Craig A Internal : Chief Executive Officer	290,387	$438,484.37	10/21/24	M 13,797 x $0 = $0
Christian Waage Internal : Director	66,180	$99,931.80	01/19/24	A 13,948 x $0 = $0
Rodriguez Susan Internal : Director	69,230	$104,537.30	01/19/24	A 13,948 x $0 = $0
Morgan Adam Internal : Director	6,986,744	$10,549,983.44	07/25/23	P 2,486,744 x $1.37 = $3,406,839.28
Johnson Craig A Internal : Director	65,820	$99,388.20	01/19/24	A 13,948 x $0 = $0
Dissanaike Sharmila Internal : Director	69,230	$104,537.30	01/19/24	A 13,948 x $0 = $0
Peraza Lisa Internal : VP, Chief Accounting Officer	53,750	$81,162.50	10/17/23	M 552 x $0 = $0
Szekeres David Leslie Internal : EVP, Chief Operating Officer	27,400	$41,374.00	04/17/23	M 1,250 x $0 = $0
Poyhonen John Internal : President & CCO	44,096	$66,584.96	04/17/23	M 1,250 x $0 = $0
Manhard Kimberly Internal : EVP, Drug Development	25,183	$38,026.33	04/17/23	M 1,250 x $0 = $0
Kotler Kevin Internal : Director	0	$0	03/02/23	0 x $0 = $0